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Systemic lupus erythematosus (SLE;
OMIM 152700) is an important disorder
of autoimmunity characterized by the
presence of antibodies to nuclear self-
antigens and the involvement of multi-
ple organs. The etiopathogenesis of SLE
is complex and is still largely unknown.
Both genetic and environmental factors
contribute to disease susceptibility
(Kyogoku and Tsuchiya, 2007). The pre-
valence of SLE and its manifestations
varies among different ethnic and geo-
graphical populations (Lau et al., 2006),
with higher prevalence rates and more
severe complications in non-European
populations. For example, higher rates
of lupus nephritis have been observed in
Asians, Hispanics, and African Americans
(Johnson et al., 1995; Seligman et al.,
2002). In contrast, higher prevalence
rates of photosensitivity have been
noted in Europeans (Ward and Studenski,
1990). Genetic heterogeneity of SLE may
underlie these ethnic differences in SLE
manifestations.
Despite considerable clinical hetero-
geneity, SLE is one of the most heritable
autoimmune diseases, with a sibling risk
ratio of B30 (Vyse and Todd, 1996).
Increased understanding of the genetic
basis for SLE is of key importance in
improving the prognosis of patients with
SLE. Recent genome-wide association
studies (GWAS) and candidate gene
studies have confirmed genetic asso-
ciations of over 40 loci with SLE risk
that achieve genome-wide significance
(Po5 108), with some of these sus-
ceptibility loci validated independently
in different populations (Cui et al.,
2013). Most of these associated gene
products participate in key pathogenic
pathways involved in the development
of SLE, such as Toll-like receptor
signaling, immune complex processing,
and type I interferon production.
The GWAS approach has been extre-
mely successful in pinpointing the asso-
ciation of common genetic variants with
diseases or disease-related quantitative
phenotypes. However, given the small
sizes of the expected effect in a poly-
genic model, individual GWAS are gen-
erally too small to provide the necessary
power to detect single-nucleotide poly-
morphism (SNP) associations while
accounting for the multiple number of
independent tests. Therefore, the genet-
ics community has widely adopted the
approach of combining summary statis-
tics from multiple GWAS into a single
meta-analysis to increase the statistical
power of the analysis by augmenting the
effective sample size. For example, we
performed meta-analysis of two existing
GWASs on Chinese Han populations
and followed the findings by further
replication in several additional Asian
cohorts, and identified genetic variants
in or near five genes as associated with
SLE: CDKN1B, TET3, CD80, DRAM1,
and ARID5B (Yang et al., 2013). In
addition, we discovered multiple inde-
pendent susceptibility variants for the
disease in the 11q23.3 region (Zhang
et al., 2014). To determine the associa-
tion with both SNPs and classical human
leukocyte antigen (HLA) alleles for SLE,
Morris et al. (2012) performed a meta-
analysis of the MHC region from six
studies and well-known out-of-study
control data sets. They found the best
model for SLE association includes both
classical loci (HLA-DRB1(*)03:01, HLA-
DRB1(*)08:01, and HLA-DQA1(*)01:02)
and two SNPs, rs8192591 and
rs2246618 (Morris et al., 2012).
Meta-analysis of GWAS was also
performed to gain insight into the com-
mon genetic basis of various autoim-
mune diseases. To explore candidate
SNPs and candidate mechanisms of
SLE and rheumatoid arthritis (RA), Lee
et al. (2012) carried out meta-analysis of
two SLE GWAS data sets in European
and Korean individuals. In addition to
the HLA region, this study identified six
SNPs associated with SLE with genome-
wide significance (STAT4, TNPO3, BLK,
FAM167A, and IRF5), and ICSNPathway
identified five candidate causal SNPs
and 13 candidate causal pathways
involved in different cellular functions,
such as bystander B-cell activation,
cytokine network, and collagen meta-
bolic processing, which may contribute
to SLE susceptibility. They also revealed
candidate causal non-HLA SNPs, genes,
and pathways involved in RA (Lee et al.,
2012). In order to reveal the genetic
basis of systemic sclerosis (SSc) and SLE,
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Martin et al. (2013) performed a pan-
meta-analysis of two GWAS together
with a replication stage. This study
identified KIAA0319L as a novel
susceptibility locus for SSc and SLE,
and they also determined that the
previously described SLE susceptibility
loci PXK and JAZF1 are shared with SSc.
In addition, Chung et al. (2014) com-
pleted a meta-analysis of three GWAS
of SLE to investigate lupus nephritis–
predisposing loci and identified multiple
susceptibility variants within four non-
HLA loci associated with this disorder,
such as 4q11-q13 (PDGFRA and GSX2),
16p12 (SLC5A11), 6p22 (ID4), and
8q24.12 (HAS2 and SNTB1). Results
from this large-scale genome-wide inve-
stigation of lupus nephritis provide
evidence for multiple biologically rele-
vant lupus nephritis susceptibility loci
(Chung et al., 2014). Meta-analysis of
GWAS, aimed at increasing the power
of studies by combining the results from
different study populations, have led to
the identification of novel associations
that would not otherwise have been
identified in individual GWASs.
Therefore, studies employing increased
sample size, meta-analysis of existing
GWAS, and trans-ethnic populations are
possible approaches that could uncover
some of the missing susceptibility var-
iants for SLE and move us toward a
better understanding of the disease and
possible intervention. Large-scale meta-
analysis clearly represents a powerful
tool for identifying novel genetic var-
iants for SLE. Although meta-analysis
can be very powerful, its application
must be executed with caution. It is
known that meta-analysis may introduce
false-positive/-negative results due to
heterogeneity and other confounding
factors. Consequently, it is important to
exert caution when designing studies,
and interpreting results generated by
meta-analysis of GWASs. In addition,
conducting these large-scale meta-ana-
lyses requires an extensive, concerted
effort in collaboration and coordination
among various research centers and
groups, as well as centralization and
standardization of data analyses. It still
needs other large-scale meta-analysis of
GWASs to reveal additional genetic risk
factors relevant to SLE risk. In addition,
further study focused on the associated
genes identified by meta-analysis of
GWAS, should advance our understand-
ing of the pathogenesis of SLE.
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